CREBBP and breast carcinoma: We noted that GI50 values for CPI-1612 were similar for ER positive breast cancer cell lines in both culture conditions (panel B in S1 Fig), demonstrating that CREBBP/EP300 inhibition can directly impact hormone-driven proliferation.